Navigation Links
Greenberg Traurig London Team Represents Long-time Client AstraZeneca AB in Two Divestment Agreements
Date:11/9/2018

The London office of global law firm Greenberg Traurig, LLP represented AstraZeneca AB on its agreement with Grünenthal to divest the European rights to Nexium for an upfront payment of USD700 million with further sales-related and milestone payments of up to USD90 million. Nexium (esomeprazole) is a proton pump inhibitor that decreases the amount of acid produced in the stomach. The law firm also represented AstraZeneca AB on its agreement with Grünenthal to divest the global rights to Vimovo in all markets excluding the US and Japan for an upfront payment of USD115 million and further payments up to another USD17 million. Vimovo combines the non-steroidal anti-inflammatory drug naproxen with esomeprazole, the active ingredient in Nexium, for patients a risk of developing ulcers.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Grünenthal is a science-based pharmaceutical company specialised in innovative pain management and related therapies. These divestments are part of several transactions in which Greenberg Traurig’s London office has represented AstraZeneca over the past eight years.

The deal was led by Adam McArthur and Warren Brown, in-house lawyers at AstraZeneca AB. Greenberg Traurig team members involved in these latest transactions included: Paul Maher, Vice Chair of Greenberg Traurig; Fiona Adams, Co-Managing Shareholder of the London office and the Co-Chair of the firm’s Global Corporate Practice; shareholders Henrietta Walker and Sarah Moyles; associates David Hirschman, Charlotte Irvine, Miles Daly, Eleni Pittas, and Declan Grady; and IP Consultant Ewen Mitchell.

“It has been an absolute pleasure to represent AstraZeneca and to work with Adam and Warren, its dynamic and commercially driven legal team,” Maher said. “We are proud to have been able to help them achieve AstraZeneca’s strategic divestment goals.”

About Greenberg Traurig’s Corporate Practice
Greenberg Traurig’s Corporate Practice comprises more than 450 lawyers in the United States, Europe, Asia, the Middle East and Latin America who regularly advise public and privately held companies, entrepreneurs and investment funds on global mergers and acquisitions, corporate restructurings, private equity and venture capital, underwritten and syndicated offerings, commercial finance and syndicated lending, cross-border transactions, and general corporate matters. The group’s industry experience includes transactions in a wide range of fields, from the pharmaceutical, medical devices, and life sciences fields, to representations involving clients in the aviation, banking, consumer products, energy, food and beverage, health care, manufacturing, media, technology, and telecommunications sectors.

About Greenberg Traurig’s London Office: Greenberg Traurig, LLP in London has established itself as a multidisciplinary law firm, with more than 80 lawyers and growing. The London office provides partner-led advice to domestic and international clients on a range of matters across the legal spectrum. Lawyers at Greenberg Traurig in London advise U.K. and multinational clients operating in many different sectors, including chemicals, pharmaceuticals, life sciences, energy, real estate, financial services, automotive, retail, and communications.

About Greenberg Traurig: Greenberg Traurig, LLP (GT) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, was named the largest firm in the U.S. by Law360 in 2017, and is among the Top 20 on the 2018 Am Law Global 100. Web: http://www.gtlaw.com; Twitter: @GT_Law.

Read the full story at https://www.prweb.com/releases/greenberg_traurig_london_team_represents_long_time_client_astrazeneca_ab_in_two_divestment_agreements/prweb15906696.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Archbishop Desmond Tutu Advocates St John International Charity Work on Packed London Visit and Audience with HM The Queen
2. UKs Flagship Health & Safety Event Has Successful Inaugural Year in London
3. genae Opens Offices in London
4. FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database
5. Klinische Studie von LKC Technologies bestätigt kosteneffektive Alternative zum Goldstandard beim Screening auf diabetische Retinopathie. Einzelheiten werden beim EURETINA/ESCRS in London bekanntgegeben
6. NW BIO CEO TO PRESENT AT SMis 3rd ANNUAL CANCER VACCINES CONFERENCE IN LONDON
7. FDNA to Exhibit at ASHG2014 Presenting Face2Gene Integrated With London Medical Databases (LMD) Online
8. FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à lASHG 2014
9. Process Validation in the US and EU (Workshop, London)
10. New Cancer Center at Guys Hospital in London to be Equipped with Varian TrueBeam Treatment Machines
11. TapImmune Appoints David Laskow-Pooley, CEO of London Pharma, to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/19/2019)... ... July 19, 2019 , ... Cloudticity, ... of Chris Whaley as Senior Vice President of Business Development. , Whaley ... experience better using cloud technology. , As a technology leader with more than ...
(Date:7/19/2019)... ... July 19, 2019 , ... Robinson Pharma, Inc., is proud to ... facilities was audited by the Safe Quality Food (SQF) Institute using an accredited certification ... Safety Code for Manufacturing, Edition 8. , The SQF Certification program is trusted by ...
(Date:7/18/2019)... ... July 18, 2019 , ... ComplianceLine, the ... 20 years, announced today it is moving into new corporate headquarters in Charlotte ... are thrilled to be moving into the new office which will allow our ...
Breaking Medicine Technology:
(Date:7/18/2019)... , ... July 18, 2019 , ... Gateway Genomics ... children, announces a new publication titled, “ Accurate Fetal Sex Determination from Maternal Blood ... In the study, DNA blood samples were collected from 108 women at an average ...
(Date:7/17/2019)... ... July 17, 2019 , ... The ... online Family Nurse Practitioner program. The honor is given to distance learning courses ... , The Catalyst Awards honor institutions from around the world that produce exemplary ...
(Date:7/17/2019)... SAINT PAUL, Minn. (PRWEB) , ... July 17, ... ... created to assist healthcare providers working with the ICD-10 coding set, is launching ... listeners Continuing Education Units (CEUs) at no additional charge, officials announced this week. ...
(Date:7/17/2019)... YORK (PRWEB) , ... July 17, 2019 , ... A ... the Journal of the American Medical Association (JAMA), shows for the first ... sepsis deaths in the state. Sepsis is the body’s extreme response to infection. It ...
(Date:7/17/2019)... ... , ... Dr. Jonathan Zaidan, MD, FACOG, President of Women’s Excellence discusses a ... The show airs on Wednesday, July 17ths at 7pm. The show podcast will ... Ann Thomas discuss the challenges that women face when it comes to weight loss ...
Breaking Medicine News(10 mins):